A Rapid Derivative Spectrophotometric Method for Simultaneous Determination of Naphazoline and Antazoline in Eye Drops

A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate in eye drops. The measurements were carried out at wavelengths of 225 and 252 nm for naphazoline hydrochloride and antazoline phosphate, resp...

Full description

Saved in:
Bibliographic Details
Published in:Chemical & Pharmaceutical Bulletin Vol. 54; no. 1; pp. 119 - 122
Main Authors: Souri, Effat, Amanlou, Massoud, Farsam, Hassan, Afshari, Alma
Format: Journal Article
Language:English
Published: Japan The Pharmaceutical Society of Japan 2006
Pharmaceutical Society of Japan
Japan Science and Technology Agency
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate in eye drops. The measurements were carried out at wavelengths of 225 and 252 nm for naphazoline hydrochloride and antazoline phosphate, respectively. The method was found to be linear (r2>0.999) in the range of 0.2—1 μg/ml for naphazoline hydrochloride in the presence of 5 μg/ml antazoline phosphate at 225 nm. The same linear correlation (r2>0.999) was obtained in the range of 1—10 μg/ml of antazoline phosphate in the presence of 0.5 μg/ml of naphazoline hydrochloride at 252 nm. The limit of determination was 0.2 μg/ml and 1 μg/ml for naphazoline hydrochloride and antazoline phosphate, respectively. The method was successfully used for simultaneous analysis of naphazoline hydrochloride and antazoline phosphate in eye drops without any interference from excipients and prior separation before analysis.
AbstractList A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate in eye drops. The measurements were carried out at wavelengths of 225 and 252 nm for naphazoline hydrochloride and antazoline phosphate, respectively. The method was found to be linear (r2>0.999) in the range of 0.2—1 μg/ml for naphazoline hydrochloride in the presence of 5 μg/ml antazoline phosphate at 225 nm. The same linear correlation (r2>0.999) was obtained in the range of 1—10 μg/ml of antazoline phosphate in the presence of 0.5 μg/ml of naphazoline hydrochloride at 252 nm. The limit of determination was 0.2 μg/ml and 1 μg/ml for naphazoline hydrochloride and antazoline phosphate, respectively. The method was successfully used for simultaneous analysis of naphazoline hydrochloride and antazoline phosphate in eye drops without any interference from excipients and prior separation before analysis.
A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate in eye drops. The measurements were carried out at wavelengths of 225 and 252 nm for naphazoline hydrochloride and antazoline phosphate, respectively. The method was found to be linear (γ2>0.999) in the range of 0.2-1μg/ml for naphazoline hydrochloride in the presence of 5μg/ml antazoline phosphate at 225 nm. The same linear correlation (γ2>0.999) was obtained in the range of 110μg/ml of antazoline phosphate in the presence of 0.5μg/ml of, naphazoline hydrochloride at 252 nm. The limit of determination was 0.2μg/ml and 1μg/ml for naphazoline hydrochloride and antazoline phosphate, respectively. The method was successfully used for simultaneous analysis of naphazoline hydrochloride and antazoline phosphate in eye drops without any interference from excipients and prior separation before analysis.
A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate in eye drops. The measurements were carried out at wavelengths of 225 and 252 nm for naphazoline hydrochloride and antazoline phosphate, respectively. The method was found to be linear (r2>0.999) in the range of 0.2-1 microg/ml for naphazoline hydrochloride in the presence of 5 microg/ml antazoline phosphate at 225 nm. The same linear correlation (r2>0.999) was obtained in the range of 1-10 microg/ml of antazoline phosphate in the presence of 0.5 microg/ml of naphazoline hydrochloride at 252 nm. The limit of determination was 0.2 microg/ml and 1 microg/ml for naphazoline hydrochloride and antazoline phosphate, respectively. The method was successfully used for simultaneous analysis of naphazoline hydrochloride and antazoline phosphate in eye drops without any interference from excipients and prior separation before analysis.
A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate in eye drops. The measurements were carried out at wavelengths of 225 and 252 nm for naphazoline hydrochloride and antazoline phosphate, respectively. The method was found to be linear (r2>0.999) in the range of 0.2-1 microg/ml for naphazoline hydrochloride in the presence of 5 microg/ml antazoline phosphate at 225 nm. The same linear correlation (r2>0.999) was obtained in the range of 1-10 microg/ml of antazoline phosphate in the presence of 0.5 microg/ml of naphazoline hydrochloride at 252 nm. The limit of determination was 0.2 microg/ml and 1 microg/ml for naphazoline hydrochloride and antazoline phosphate, respectively. The method was successfully used for simultaneous analysis of naphazoline hydrochloride and antazoline phosphate in eye drops without any interference from excipients and prior separation before analysis.
Author Afshari, Alma
Farsam, Hassan
Souri, Effat
Amanlou, Massoud
Author_xml – sequence: 1
  fullname: Souri, Effat
  organization: Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences
– sequence: 2
  fullname: Amanlou, Massoud
  organization: Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences
– sequence: 3
  fullname: Farsam, Hassan
  organization: Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences
– sequence: 4
  fullname: Afshari, Alma
  organization: Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16394564$$D View this record in MEDLINE/PubMed
BookMark eNpdkU2LFDEQhoOsuLOrF3-ABAQPwoz56nT6JMN-qLAquHoO6XS1k6E76U0yA-uvN0OPs-ClkqKeeuul6gKd-eABodeUrCgT6oOd2lUlVpQ2z9CCclEvK8b4GVoQQpol45Kfo4uUtoSwitT8BTqnkjeikmKB9mv8w0yuw9cQ3d5ktwd8P4HNMUybkMMIOTqLv0LehA73IeJ7N-6GbDyEXSpdGeLofGkMHocefzPTxvwJg_OAje_w2ud_qfP45hHwdVFOL9Hz3gwJXh3fS_Tr9ubn1efl3fdPX67Wd0srlchLaBgoxTomWUt7rkgniQTJlax5K0BJ0jMiW1UzEKxljNqqrnjfW1qzRtmKX6J3s-4Uw8MOUtajSxaGYfavZS1JwxpSwLf_gduwi75401RIwlWtxIF6P1M2hpQi9HqKbjTxUVOiD7fQ5Ra6ErrcosBvjpK7doTuCT0uvwC3M1Cqzpoh-MOengbbVNsNjE4zQqQmpBKEasLKt8iXIBkr1quDrY-z0DZl8xtOk0zMzg5wMjWHQ_OpsjFRg-d_AT5Hsw4
CitedBy_id crossref_primary_10_1016_j_aca_2008_12_039
crossref_primary_10_1039_C5NJ03334A
crossref_primary_10_1039_C0AN00343C
crossref_primary_10_1007_s10895_009_0526_3
crossref_primary_10_5402_2012_917879
crossref_primary_10_1007_s10847_007_9377_1
crossref_primary_10_1186_s13065_022_00819_9
crossref_primary_10_18596_jotcsa_450793
crossref_primary_10_1016_S1452_3981_23_16275_4
crossref_primary_10_3892_mmr_2016_4937
crossref_primary_10_1080_10826076_2012_668736
crossref_primary_10_1016_j_microc_2024_110702
crossref_primary_10_1080_10826070802711113
crossref_primary_10_1002_bio_1297
crossref_primary_10_1016_j_rechem_2023_100920
crossref_primary_10_1016_j_jchromb_2013_04_021
crossref_primary_10_1016_j_jpha_2013_03_008
crossref_primary_10_1186_1752_153X_8_7
crossref_primary_10_1134_S1061934815030041
crossref_primary_10_1016_j_ijleo_2019_164010
crossref_primary_10_1038_s41598_023_46940_0
crossref_primary_10_1080_10826076_2013_789802
crossref_primary_10_1039_D0RA10598H
Cites_doi 10.1016/S0731-7085(01)00394-6
10.1016/S0731-7085(01)00627-6
10.1002/jps.2600680920
10.1016/S0731-7085(03)00347-9
10.1002/jps.2600670143
10.1016/S0731-7085(00)00596-3
10.1016/S0731-7085(01)00428-9
10.1111/j.2042-7158.1972.tb09050.x
10.1016/S0731-7085(01)00556-8
10.1016/S0731-7085(01)00664-1
10.1016/S0731-7085(03)00429-1
10.1016/S0731-7085(00)00600-2
10.1016/S0731-7085(02)00065-1
10.1016/S0731-7085(01)00388-0
10.1016/S0731-7085(01)00583-0
10.1016/S0731-7085(02)00095-X
10.1016/S0731-7085(01)00474-5
10.1002/jps.2600840422
ContentType Journal Article
Copyright 2006 The Pharmaceutical Society of Japan
Copyright Japan Science and Technology Agency 2006
Copyright_xml – notice: 2006 The Pharmaceutical Society of Japan
– notice: Copyright Japan Science and Technology Agency 2006
CorporateAuthor Faculty of Pharmacy and Pharmaceutical Sciences Research Center University of Medical Sciences
Department of Medicinal Chemistry
CorporateAuthor_xml – name: Department of Medicinal Chemistry
– name: Faculty of Pharmacy and Pharmaceutical Sciences Research Center University of Medical Sciences
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
7TM
7U9
H94
7X8
DOI 10.1248/cpb.54.119
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList

MEDLINE
AIDS and Cancer Research Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1347-5223
EndPage 122
ExternalDocumentID 3133608961
10_1248_cpb_54_119
16394564
cs7chemi_2006_005401_026_0119_0162229050
article_cpb_54_1_54_1_119_article_char_en
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
29B
2WC
3O-
53G
5GY
6J9
AABQG
AAUGY
ABTAH
ACGFO
ACIWK
ACPRK
ADBBV
AENEX
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BKOMP
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
HH5
JMI
JSF
JSH
KQ8
L7B
MOJWN
OK1
P2P
RJT
RZJ
TKC
TR2
VH1
X7J
X7M
XSB
ZE2
ZGI
ZY4
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
7TM
7U9
H94
7X8
ID FETCH-LOGICAL-c684t-e92e882d262b1f380d606e638673b4e860f206b872e42b221c5753ffc17298c53
ISSN 0009-2363
IngestDate Fri Aug 16 05:21:00 EDT 2024
Thu Oct 10 17:39:17 EDT 2024
Fri Aug 23 01:40:40 EDT 2024
Sat Sep 28 08:39:17 EDT 2024
Fri Nov 08 06:52:50 EST 2024
Thu Aug 17 20:29:00 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c684t-e92e882d262b1f380d606e638673b4e860f206b872e42b221c5753ffc17298c53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/cpb/54/1/54_1_119/_article/-char/en
PMID 16394564
PQID 1460387840
PQPubID 1996362
PageCount 4
ParticipantIDs proquest_miscellaneous_67609290
proquest_journals_1460387840
crossref_primary_10_1248_cpb_54_119
pubmed_primary_16394564
medicalonline_journals_cs7chemi_2006_005401_026_0119_0162229050
jstage_primary_article_cpb_54_1_54_1_119_article_char_en
PublicationCentury 2000
PublicationDate 2006
20060000
2006-Jan
2006-00-00
20060101
PublicationDateYYYYMMDD 2006-01-01
PublicationDate_xml – year: 2006
  text: 2006
PublicationDecade 2000
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Tokyo
PublicationTitle Chemical & Pharmaceutical Bulletin
PublicationTitleAlternate Chem. Pharm. Bull.
PublicationYear 2006
Publisher The Pharmaceutical Society of Japan
Pharmaceutical Society of Japan
Japan Science and Technology Agency
Publisher_xml – name: The Pharmaceutical Society of Japan
– name: Pharmaceutical Society of Japan
– name: Japan Science and Technology Agency
References 15) El-Ragehy N. A., Badawey A. M., Elkhateeb S. Z., J. Pharm. Biomed. Anal., 28, 1041—1053 (2002).
17) Satana E., Altinay S., Gunden Gogea N., Ozkan S. A., Senturk Z., J. Pharm. Biomed. Anal., 25, 1009—1013 (2001).
1) Abdine H., Wahbi A. M., Korany M. A., J. Pharm. Pharmacol., 24, 522—524 (1972).
5) Ruckmick S. C., March D. F., Duong S. T., J. Pharm. Sci., 84, 502—507 (1995).
3) Boon P. F. G., Sudds W., J. Pharm. Pharmacol., 19, 88S—92S (1967).
19) Erk N., J. Pharm. Biomed. Anal., 28, 391—397 (2002).
21) Lastra O. C., Lemus I. G., Sanchez H. J., Perez R. F., J. Pharm. Biomed. Anal., 33, 175—180 (2003).
8) Erk N., J. Pharm. Biomed. Anal., 26, 43—52 (2001).
10) Castro D., Moreno M. A., Lastres J. L., J. Pharm. Biomed. Anal., 26, 563—572 (2001).
16) El-Gindy A., El-Zeany B., Awad T., Shabana M. M., J. Pharm. Biomed. Anal., 26, 203—210 (2001).
6) Karpinska J., Mulikowska M., J. Pharm. Biomed. Anal., 29, 53—58 (2002).
11) Trabelsi H., Raouafi F., Limam M., Bousouita K., J. Pharm. Biomed. Anal., 29, 239—245 (2002).
9) Vega E., Sola N., J. Pharm. Biomed. Anal., 25, 523—530 (2001).
4) Koziol T. R., Jacob J. T., Achari R. G., J. Pharm. Sci., 68, 1135—1138 (1979).
7) Senturk N., Erk S. A., Ozkan C., Akay S., J. Pharm. Biomed. Anal., 29, 291—298 (2002).
14) Hasan N. Y., Elkway M. A., Elzeany B. E., Wagieh N. E., J. Pharm. Biomed. Anal., 28, 187—197 (2002).
18) Prasad C. V. N., Parihar Ch., Chowdhary T. R., Purohit S., Parimoo P., Pharm. Pharmacol. Commun., 4, 325—330 (1998).
13) Ragno G., Garofalo A., Vetuschi C., J. Pharm. Biomed. Anal., 27, 19—24 (2002).
20) Markopoulou C. K., Koundourelllis J. E., J. Pharm. Biomed. Anal., 33, 1163—1173 (2003).
2) Wahbi A. M., Abdine H., Korany M. A., El-Yazbi F. A., J. Pharm. Sci., 67, 140—141 (1978).
12) Gungor S., Onur F., J. Pharm. Biomed. Anal., 25, 511—521 (2001).
11
Abdine H., Wahbi A. M., Korany M. A. (1) 1972; 24
12
Boon P. F. G., Sudds W. (3) 1967; 19
13
16
17
19
(4) 1979; 68
Hasan N. Y., Elkway M. A., Elzeany B. E., Wagieh N. E. (14) 2002; 28
Karpinska J., Mulikowska M. (6) 2002; 29
7
Prasad C. V. N., Parihar Ch., Chowdhary T. R., Purohit S., Parimoo P. (18) 1998; 4
8
9
(5) 1995; 84
Lastra O. C., Lemus I. G., Sanchez H. J., Perez R. F. (21) 2003; 33
Wahbi A. M., Abdine H., Korany M. A., El-Yazbi F. A. (2) 1978; 67
El-Ragehy N. A., Badawey A. M., Elkhateeb S. Z. (15) 2002; 28
20
10
References_xml – ident: 17
  doi: 10.1016/S0731-7085(01)00394-6
– ident: 19
  doi: 10.1016/S0731-7085(01)00627-6
– volume: 68
  start-page: 1135
  issn: 0022-3549
  issue: 9
  year: 1979
  ident: 4
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.2600680920
– volume: 33
  start-page: 175
  issn: 0731-7085
  year: 2003
  ident: 21
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/S0731-7085(03)00347-9
  contributor:
    fullname: Lastra O. C., Lemus I. G., Sanchez H. J., Perez R. F.
– volume: 67
  start-page: 140
  issn: 0022-3549
  year: 1978
  ident: 2
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.2600670143
  contributor:
    fullname: Wahbi A. M., Abdine H., Korany M. A., El-Yazbi F. A.
– ident: 9
  doi: 10.1016/S0731-7085(00)00596-3
– ident: 16
  doi: 10.1016/S0731-7085(01)00428-9
– volume: 19
  start-page: 88S
  issn: 0022-3573
  year: 1967
  ident: 3
  publication-title: J. Pharm. Pharmacol.
  contributor:
    fullname: Boon P. F. G., Sudds W.
– volume: 4
  start-page: 325
  year: 1998
  ident: 18
  publication-title: Pharm. Pharmacol. Commun.
  contributor:
    fullname: Prasad C. V. N., Parihar Ch., Chowdhary T. R., Purohit S., Parimoo P.
– volume: 24
  start-page: 522
  issn: 0022-3573
  year: 1972
  ident: 1
  publication-title: J. Pharm. Pharmacol.
  doi: 10.1111/j.2042-7158.1972.tb09050.x
  contributor:
    fullname: Abdine H., Wahbi A. M., Korany M. A.
– ident: 13
  doi: 10.1016/S0731-7085(01)00556-8
– volume: 28
  start-page: 1041
  issn: 0731-7085
  year: 2002
  ident: 15
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/S0731-7085(01)00664-1
  contributor:
    fullname: El-Ragehy N. A., Badawey A. M., Elkhateeb S. Z.
– ident: 20
  doi: 10.1016/S0731-7085(03)00429-1
– ident: 12
  doi: 10.1016/S0731-7085(00)00600-2
– ident: 7
  doi: 10.1016/S0731-7085(02)00065-1
– ident: 8
  doi: 10.1016/S0731-7085(01)00388-0
– volume: 28
  start-page: 187
  issn: 0731-7085
  year: 2002
  ident: 14
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/S0731-7085(01)00583-0
  contributor:
    fullname: Hasan N. Y., Elkway M. A., Elzeany B. E., Wagieh N. E.
– ident: 11
  doi: 10.1016/S0731-7085(02)00095-X
– volume: 29
  start-page: 53
  issn: 0731-7085
  year: 2002
  ident: 6
  publication-title: J. Pharm. Biomed. Anal.
  contributor:
    fullname: Karpinska J., Mulikowska M.
– ident: 10
  doi: 10.1016/S0731-7085(01)00474-5
– volume: 84
  start-page: 502
  issn: 0022-3549
  issue: 4
  year: 1995
  ident: 5
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.2600840422
SSID ssj0025073
ssib023156984
ssib014648066
ssib002822113
ssib017383858
Score 1.9256036
Snippet A zero-crossing first-derivative spectrophotometric method is applied for the simultaneous determination of naphazoline hydrochloride and antazoline phosphate...
SourceID proquest
crossref
pubmed
medicalonline
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 119
SubjectTerms Adrenergic alpha-Agonists - analysis
Antazoline - analysis
antazoline phosphate
Anti-Allergic Agents - analysis
Calibration
derivative spectrophotometry
eye drops
Indicators and Reagents
Naphazoline - analysis
naphazoline hydrochloride
Ophthalmic Solutions - analysis
Reference Standards
Reproducibility of Results
Spectrophotometry, Ultraviolet
Title A Rapid Derivative Spectrophotometric Method for Simultaneous Determination of Naphazoline and Antazoline in Eye Drops
URI https://www.jstage.jst.go.jp/article/cpb/54/1/54_1_119/_article/-char/en
http://mol.medicalonline.jp/en/journal/download?GoodsID=cs7chemi/2006/005401/026&name=0119-0162e
https://www.ncbi.nlm.nih.gov/pubmed/16394564
https://www.proquest.com/docview/1460387840
https://search.proquest.com/docview/67609290
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Chemical and Pharmaceutical Bulletin, 2006, Vol.54(1), pp.119-122
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Za9tAEF7StA-FUnrXbdoutOTFUaJjreOpiNohPeIEH9A3Ickr7NBIJrID7q_vN1odVkMhpRTDYuuypO_T7Hyr2RnGPni6MELHNbTQErom8ABpoRPFAAQfLzKlOaPJySdjZ_jd7Q_EYGenqqzZLPuvSGMZsKaZs3-Bdn1QLMB3YI4WqKO9Fe5-dxQuFxRefFUULruWRY351VW2nGer7JIqaMXd06JwdBFjOF5QUGGYSgqG7VfRMZUjOQyX8_BnVjijNMbup6vq5yLtDjay28eR820ft85BQKw6n7fGzFvZvsmRT5Jw1R2fTUf16O0p3PlsjX869YffzqaNicxz2KJjfzRughL8H5dh1z8en_jl_vX4Rc21306gilLFpX2Bn5C2rLanmVZpCEurrVJPt9ipTLBRmmDVmxvK1t_oKExBkx_iZXTYE4f1Lq3E23HuxHTDqFInxf7BtzUCSNaA0uShsakUuk7jRXdNWDkq3ND__HVby0Jc18YPPZJwt1LnG47lbicSgp_dsz2aNFyOFsBRr8sA0sWXuXVx4kfNabe8qXsXEBSUKeLBpXrJp5Kt_Fk7FT7U5BF7WIof7ivWPmY7F-ETtl8itDngk2YyYH7A9_l5k1d985Rd-7ygNm-ozW9Smytqc1Cbb1Obt6jNs4RvUZuD2ryhNl-kHNTmBbWfsenxYPLpRCvLhmix7YqVJj1TQjfOTNuMjMRy9RlEukQ_YztWJKRr64mp25HrmFKYEUCKIVmsJInhy3tu3LOes900S-VLxoVtWfQmHro_Er0wikJ4b70EGkZICVZ02Pvq9gdLlR0mIFUNkAKAFPQEFLbXYa5Cpt6mtA71NqohWtVrcINhzjrsYwvLoLQ0eXBbdnbYXoV-szPISGErrsDqd_VqdCz0tlChEtiOrUM7YYsXijPNFULVUBaqV_98cq_Z_WZIc4_trq7W8g27k8_Wb4uH6RdHA_fS
link.rule.ids 315,782,786,4030,27934,27935,27936
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Rapid+Derivative+Spectrophotometric+Method+for+Simultaneous+Determination+of+Naphazoline+and+Antazoline+in+Eye+Drops&rft.jtitle=Chemical+%26+Pharmaceutical+Bulletin&rft.au=Effat+SOURI&rft.au=Massoud+AMANLOU&rft.au=Hassan+FARSAM&rft.au=Alma+AFSHARI&rft.date=2006&rft.pub=Pharmaceutical+Society+of+Japan&rft.issn=0009-2363&rft.volume=54&rft.issue=1&rft.spage=119&rft.epage=162&rft_id=info:doi/10.1248%2Fcpb.54.119&rft.externalDocID=cs7chemi_2006_005401_026_0119_0162229050
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon